Compare AVAH & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVAH | UROY |
|---|---|---|
| Founded | 1984 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2021 | 2026 |
| Metric | AVAH | UROY |
|---|---|---|
| Price | $13.85 | $4.32 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $9.75 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 3.1M |
| Earning Date | 05-14-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1850.00 | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $2,433,199,000.00 | N/A |
| Revenue This Year | $7.31 | $279.20 |
| Revenue Next Year | $5.59 | N/A |
| P/E Ratio | ★ $35.57 | $1,584.46 |
| Revenue Growth | ★ 20.19 | N/A |
| 52 Week Low | $5.93 | $2.56 |
| 52 Week High | $13.61 | $5.52 |
| Indicator | AVAH | UROY |
|---|---|---|
| Relative Strength Index (RSI) | 79.20 | 72.65 |
| Support Level | $8.85 | $3.54 |
| Resistance Level | N/A | $4.48 |
| Average True Range (ATR) | 0.67 | 0.22 |
| MACD | 0.34 | 0.02 |
| Stochastic Oscillator | 95.68 | 94.49 |
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.